Pinned Tweet
I’m so thankful to my mentors and my programs who guided me and supported me through this journey. I would not have made it without them 😊
Congratulations to Mariana Correia Marques, MD, a recipient of the 2023 ACR Distinguished Fellow Award! Mariana is a clinical fellow in the NIAMS Translational Genetics and Genomics Section and studies systemic juvenile idiopathic arthritis.
#ACR23
Mariana Marques, MD retweeted
Michael Matt, newest member of our @CincyChildrens faculty, presented his work with the @carrainc FROST study, part of a collaboration with our friends @MichaelOmbrello and @MCMarquesMD
Mariana Marques, MD retweeted
Today is #WORDDay2025! An incredibly important cause to raise awareness of young rheumatic diseases and improve research, care, and support for patients. Please spread the WORD and and follow @WORDDay_org to find out more 👇
Today’s the day!
Join us for our exciting webinar later today as we celebrate WORD Day 2025!
📅 Today - Tuesday 18 March 2025 | 7 PM CET
It's not too late to register! ⬇️
🔗 Register for free: bit.ly/wordday2025
Let’s make a difference together! 🌍💙
#WORDDay2025
Mariana Marques, MD retweeted
Dr. Mariana Correia Marques, a NIAMS Intramural researcher focusing on juvenile idiopathic arthritis, was recently highlighted by the Childhood Arthritis and Rheumatology Research Alliance (@carrainc).
Read their spotlight: carragroup.org/blog/carra-me…
@MCMarquesMD @IRPatNIH
Very honored to have been selected as the member spotlight for @carrainc this month.
This organization played a very important role in my training, and gave me great opportunities. I’m very glad to be an active part of it 😊
carragroup.org/blog/carra-me…
Mariana Marques, MD retweeted
AlloHSCT for refractory sJIA-LD.
Congrats @GrantSchulert, Rebecca, ...
and @sjiafoundation - whose session at a NextGen a few years ago made it clear how much this was needed.
thelancet.com/journals/lanrh…
Mariana Marques, MD retweeted
PReS is launching the “PReS Introductory Course on Pediatric Rheumatology”, a new educational initiative.This programme will be a 2-year webinar series, featuring monthly aligned with the PReS syllabus. The recordings will be available (for free!) for PReS members
#ACR24 is officially over, but we still have so much to catch up on content!
(Somehow it feels like the sessions you want to watch are all at the same time).
Very thankful for the recorded videos 🙏🏼
#ACRAmbassador
LISTEN in as Dr. Kaser explains his thoughts on new therapies being developed for macrophage activation syndrome → acr.tw/4ergzxX #ACR24 @ACR_Journals
Mariana Marques, MD retweeted
👉🏼 @Amansharmapgi presenting a DADA2 Cohort of 101 Patients from 🇮🇳
Take home messages:
🔸”DADA2 is no longer a disease of the children”
🔸Mesenteric ischemia, stroke and non-usage of anti-TNF are predictors of mortality
#DADA2 #ACR24 #ACR2024 #vasculitis
Awesome session on how to interpret genetic sequencing for patients suspected of inborn errors of immunity.
Here are some hints suggestive of a genetic immune disease
#ACR24
And what to do with VUS?
Keep calm and Google it!
Great resources to look at!
#ACR24
Congratulations @DidemSayginMD and Dr Kaveh Ardalan!
Both amazing people who were extremely deserving! ❤️⭐️
Thank you for the highlight and glad to finally meet in person with #RheumChampion @realcc #ACR24 @RheumResearch
1
11
649
Mariana Marques, MD retweeted
Congrats to 💫 @DidemSayginMD!! #ACR24
Thank you for the highlight and glad to finally meet in person with #RheumChampion @realcc #ACR24 @RheumResearch
It is a true mission impossible to get consensus on what to do in sJIA lung disease. Unfortunately I couldn’t get the picture of the first question, but it was an event split 4 ways.
=X
1
181
































